OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 02/17/2023
Week ended 02/17/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 02/17/2023
The Largest Closed M&A Deal of the Week:
- On February 13, 2023, Alleaves Inc. (Private), a provider of ERP software systems to the cannabis industry, announced its purchase of Bio-Tech Medical Software, Inc. (BioTrack) from Forian Inc. (FORA: Nasdaq) for a total purchase price of $30M.
- $20M of the consideration was paid in cash at closing, and an additional $10M will be delivered in twelve equal monthly installments, subject to working capital adjustments.
- Alleaves believes the transaction will accelerate its path to positive EBITDA.
Week ended 02/17/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.